Germline landscape of BRCAs by 7-site collaborations as a BRCA consortium in Turkey.

Autor: Bisgin A; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center) and Medical Genetics Department of Medical Faculty, Adana, Turkey; InfoGenom, Cukurova Technopolis, Adana, Turkey. Electronic address: abisgin@yahoo.com., Sag SO; Bursa Uludag University, Faculty of Medicine, Department of Medical Genetics, Bursa, Turkey., Dogan ME; Erciyes University, Faculty of Medicine, Department of Medical Genetics, Kayseri, Turkey., Yildirim MS; Necmettin Erbakan University, Meram Faculty of Medicine, Department of Medical Genetics, Konya, Turkey., Gumus AA; Manisa Celal Bayar University, Faculty of Medicine, Department of Medical Genetics, Manisa, Turkey., Akkus N; Health Sciences University, Kocaeli Derince Training and Research Hospital, Department of Medical Genetics, Kocaeli, Turkey., Balasar O; Health Sciences University, Konya City Hospital, Department of Medical Genetics, Konya, Turkey., Durmaz CD; Health Sciences University, Gazi Yasargil Training and Research Hospital, Department of Medical Genetics, Diyarbakir, Turkey; Hacettepe University, Faculty of Medicine, Department of Medical Genetics, Ankara, Turkey., Eroz R; Duzce University, Faculty of Medicine, Department of Medical Genetics, Duzce, Turkey., Altiner S; Health Sciences University, Kanuni Training and Research Hospital, Department of Medical Genetics, Trabzon, Turkey; Ankara University, Faculty of Medicine, Department of Medical Genetics, Ankara, Turkey., Alemdar A; Bursa Uludag University, Institute of Health Sciences, Department of Translational Medicine, Bursa, Turkey., Aliyeva L; Bursa Uludag University, Faculty of Medicine, Department of Medical Genetics, Bursa, Turkey., Boga I; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center) and Medical Genetics Department of Medical Faculty, Adana, Turkey; InfoGenom, Cukurova Technopolis, Adana, Turkey., Cam FS; Manisa Celal Bayar University, Faculty of Medicine, Department of Medical Genetics, Manisa, Turkey., Dogan B; Bursa Uludag University, Faculty of Medicine, Department of Medical Genetics, Bursa, Turkey; Bursa Uludag University, Institute of Health Sciences, Department of Translational Medicine, Bursa, Turkey., Esbah O; Duzce University, Faculty of Medicine, Department of Medical Oncology, Duzce, Turkey., Hanta A; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center) and Medical Genetics Department of Medical Faculty, Adana, Turkey; InfoGenom, Cukurova Technopolis, Adana, Turkey., Mujde C; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center) and Medical Genetics Department of Medical Faculty, Adana, Turkey; InfoGenom, Cukurova Technopolis, Adana, Turkey., Ornek C; Bursa Uludag University, Institute of Health Sciences, Department of Translational Medicine, Bursa, Turkey., Ozer S; InfoGenom, Cukurova Technopolis, Adana, Turkey., Rencuzogullari C; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center) and Medical Genetics Department of Medical Faculty, Adana, Turkey; InfoGenom, Cukurova Technopolis, Adana, Turkey., Sonmezler O; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center) and Medical Genetics Department of Medical Faculty, Adana, Turkey., Bozdogan ST; Cukurova University AGENTEM (Adana Genetic Diseases Diagnosis and Treatment Center) and Medical Genetics Department of Medical Faculty, Adana, Turkey., Dundar M; Erciyes University, Faculty of Medicine, Department of Medical Genetics, Kayseri, Turkey., Temel SG; Bursa Uludag University, Faculty of Medicine, Department of Medical Genetics, Bursa, Turkey; Bursa Uludag University, Institute of Health Sciences, Department of Translational Medicine, Bursa, Turkey.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2022 Oct; Vol. 65, pp. 15-22. Date of Electronic Publication: 2022 Jun 21.

Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of BEAM and High-Dose ICE

Autor: Esbah O, Emre Tekgündüz, Fevzi Altuntaş, Ömür Kayıkçı, G. Durgun, Civriz Bozdağ S, Ayşegül Tetik, A.H. Kaya, Şirinoğlu Demiriz I, Şerife Koçubaba

Publikováno v: Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 33, Iss 3, Pp 209-215 (2016)

High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (AHCT) is a well-defined treatment modality for relapsed/refractory non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL). Although there are several options in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdab6c7e52037cd39e5f65d0ea2cc84e
http://europepmc.org/articles/PMC5111466

Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)

Autor: Esbah, O., Demirci, U., Dane, F., Gunaydsin, Y., Ozdemir, N., Ekinci, A. S., Kodaz, H., Yazilitas, D., Rzayev, R., Guney, Y., Seker, M., Uysal, M., Inal, A., Bilici, A., mustafa benekli, Oksuzoglu, B., Buyukberber, S.

Publikováno v: Web of Science
Scopus-Elsevier

WOS: 000376829900023
PubMed ID: 27273958
Purpose: Medulloblastoma (MB) is rarely seen in adults. For adjuvant therapy in adults the same therapy protocols used in pediatric cases are used. The present study retrospectively evaluated the dat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e1035518258d026d06b297545a7d8680
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/94041

Prognostic significance of ER-to-PR difference in ER+/HER2- early breast cancer.

Autor: Wu, Xiaoyan^1,2 (AUTHOR), Zhang, Wenchuan^1,2 (AUTHOR), Lu, Xunxi^1,2 (AUTHOR), Zhong, Xiaorong³ (AUTHOR) zhongxiaorong@126.com, Bu, Hong^1,2 (AUTHOR)

Publikováno v: Scientific Reports. 10/18/2024, Vol. 14 Issue 1, p1-10. 10p.

化生性乳腺癌临床病理特征及诊疗分析.

Autor: 郜海涛¹, 魏 娅¹ wyxb929@126.com

Publikováno v: Journal of Modern Medicine & Health. 9/15/2024, Vol. 40 Issue 17, p2931-2935. 5p.